78 / 84
top specialty drugs by plan paid - SOUTHCOMM
Date Submitted: Apr 16 - Jun 16 vs Jan 16 - Mar 16
Apr 16 - Jun 16
Curr
Rank
Prev
Rank
Drug Name
Therapeutic Class Name
Plan Paid
Utilizers
Rxs
Plan Paid Per
Rx
Plan Paid
PMPM
Rxs PMPM
Pct
Change
Plan Paid
PMPMPct
Change
Pct
Specialty
Plan Paid
1
7
XELJANZ
Chronic Inflammatory Disease
$8,398
1
3
$2,799.42
$5.65
226.0%
4,384.7%
32.4%
2
4
TRIUMEQ
HIV-Multiclass Combo
$7,454
1
3
$2,484.73
$5.01
8.7%
88.6%
28.8%
3
2
HUMIRA PEN
Chronic Inflammatory Disease
$3,811
1
1
$3,810.70
$2.56
-63.8%
-63.7%
14.7%
4
TRUVADA
HIV-Multiclass Combo
$2,754
1
3
$917.83
$1.85
10.6%
5
5
ADEFOVIR DIPIVOXIL
Hepatitis B
$1,899
1
2
$949.49
$1.28
8.7%
11.6%
7.3%
6
NEVIRAPINE ER
HIV-NNRTI
$1,054
1
3
$351.34
$0.71
4.1%
7
6
ENOXAPARIN SODIUM
Injectable Anticoagulants
$534
1
1
$534.03
$0.36
-63.8%
-62.6%
2.1%
8
1
ADVATE
Antihemophilic Products
$0
0
0
$0.00
$0.00
-100.0%
-100.0%
0.0%
9
ENBREL SURECLICK
Chronic Inflammatory Disease
$0
0
0
$0.00
$0.00
0.0%
10
3
ATRIPLA
HIV-Multiclass Combo
$0
0
0
$0.00
$0.00
-100.0%
-100.0%
0.0%
Totals:
$25,904
16
$1,618.98
$17.42
8.7%
-76.1%
100.0%
Specialty Plan Totals:
$25,904
16
$1,618.98
$17.42
8.7%
-76.1%